First filing consolidates Sinovac's HFMD vaccine lead
This article was originally published in Scrip
Executive Summary
The Chinese firm Sinovac Biotech has made the first approval filing worldwide for a prophylactic vaccine for human hand, foot and mouth disease (HFMD) caused by enterovirus 71, moving well clear of its few competitors in the field.